Similar articles for PMID: 30009057

Year	Number of Results
1996	1
2006	1
2008	3
2009	11
2010	8
2011	6
2012	9
2013	10
2014	8
2015	5
2016	7
2017	10
2018	9
2019	10
2020	8
2021	3
2022	1
2023	1
2024	0

1

Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon.

Fakhri GB, Akel RS, Khalil MK, Mukherji DA, Boulos FI, Tfayli AH. Fakhri GB, et al. Int J Breast Cancer. 2018 May 31;2018:8530318. doi: 10.1155/2018/8530318. eCollection 2018. Int J Breast Cancer. 2018. PMID: 30009057 Free PMC article.

2

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.

Mouttet D, Laé M, Caly M, Gentien D, Carpentier S, Peyro-Saint-Paul H, Vincent-Salomon A, Rouzier R, Sigal-Zafrani B, Sastre-Garau X, Reyal F. Mouttet D, et al. PLoS One. 2016 Feb 1;11(2):e0146474. doi: 10.1371/journal.pone.0146474. eCollection 2016. PLoS One. 2016. PMID: 26829108 Free PMC article.

3

Concordance of breast cancer biomarker status between routine immunohistochemistry/in situ hybridization and Oncotype DX qRT-PCR with investigation of discordance, a study of 591 cases.

Sechrist H, Glasgow A, Bomeisl P, Gilmore H, Harbhajanka A. Sechrist H, et al. Hum Pathol. 2020 Oct;104:54-65. doi: 10.1016/j.humpath.2020.07.022. Epub 2020 Aug 3. Hum Pathol. 2020. PMID: 32758491

4

Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer.

Roepman P, Horlings HM, Krijgsman O, Kok M, Bueno-de-Mesquita JM, Bender R, Linn SC, Glas AM, van de Vijver MJ. Roepman P, et al. Clin Cancer Res. 2009 Nov 15;15(22):7003-11. doi: 10.1158/1078-0432.CCR-09-0449. Epub 2009 Nov 3. Clin Cancer Res. 2009. PMID: 19887485

5

An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.

Wesseling J, Tinterri C, Sapino A, Zanconati F, Lutke-Holzik M, Nguyen B, Deck KB, Querzoli P, Perin T, Giardina C, Seitz G, Guinebretière JM, Barone J, Dekker L, de Snoo F, Stork-Sloots L, Roepman P, Watanabe T, Cusumano P. Wesseling J, et al. Virchows Arch. 2016 Sep;469(3):297-304. doi: 10.1007/s00428-016-1979-9. Epub 2016 Jul 4. Virchows Arch. 2016. PMID: 27377889

6

Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.

Vohra P, Buelow B, Chen YY, Serrano M, Vohra MS, Berry A, Ljung BM. Vohra P, et al. Cancer Cytopathol. 2016 Nov;124(11):828-835. doi: 10.1002/cncy.21745. Epub 2016 Jun 17. Cancer Cytopathol. 2016. PMID: 27315045 Free article.

7

Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.

Neely C, You S, Mendoza PM, Aneja R, Sahin AA, Li X. Neely C, et al. Breast J. 2018 Nov;24(6):889-893. doi: 10.1111/tbj.13110. Epub 2018 Sep 19. Breast J. 2018. PMID: 30230095

8

Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast.

Lin Y, Hatem J, Wang J, Quinn A, Hicks D, Tang P. Lin Y, et al. Biotech Histochem. 2011 Oct;86(5):345-50. doi: 10.3109/10520295.2010.502845. Epub 2010 Aug 12. Biotech Histochem. 2011. PMID: 20701550

9

Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material.

Berghuis AMS, van Deurzen CHM, Koffijberg H, Terstappen LWMM, Sleijfer S, IJzerman MJ. Berghuis AMS, et al. Breast Cancer Res Treat. 2019 Jun;175(2):451-458. doi: 10.1007/s10549-019-05141-y. Epub 2019 Feb 13. Breast Cancer Res Treat. 2019. PMID: 30756285 Free PMC article.

10

ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.

Filipits M, Rudas M, Singer CF, Fitzal F, Bago-Horvath Z, Greil R, Balic M, Lax SF, Halper S, Hulla W, Wu NC, Liu X, Weidler J, Bates M, Hlauschek D, Gnant M, Dubsky P. Filipits M, et al. ESMO Open. 2021 Aug;6(4):100228. doi: 10.1016/j.esmoop.2021.100228. Epub 2021 Aug 7. ESMO Open. 2021. PMID: 34371382 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year